The more fat and cholesterol packed inside a person’s artery plaque, the more the immune cells inside it are dividing — suggesting the fat itself is fueling their growth.
Scientific Claim
In human atherosclerotic plaques, the amount of lipid content is positively correlated with the rate of macrophage proliferation, indicating that lipid accumulation within plaques may directly stimulate local immune cell division.
Original Statement
“Macrophage proliferation correlated positively with both serum LDL-cholesterol levels (r = 0.69) and plaque lipid contents (r = 0.63).”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The claim correctly uses 'correlated' and reports the Pearson’s r value, matching the observational nature of the human biopsy data. No causal language is used.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Randomized Controlled TrialLevel 1bWhether reducing intraplaque lipid content directly reduces macrophage proliferation in humans, independent of serum LDL.
Whether reducing intraplaque lipid content directly reduces macrophage proliferation in humans, independent of serum LDL.
What This Would Prove
Whether reducing intraplaque lipid content directly reduces macrophage proliferation in humans, independent of serum LDL.
Ideal Study Design
A double-blind RCT of 80 patients with carotid stenosis, randomized to intraplaque lipid removal via atherectomy + LDL-lowering vs. LDL-lowering alone, with paired biopsies measuring Ki67+ macrophages and lipid content at baseline and 12 weeks.
Limitation: Invasive procedure limits feasibility and ethical approval; confounded by procedural inflammation.
Prospective Cohort StudyLevel 2bWhether plaque lipid content predicts future macrophage proliferation rates in untreated individuals.
Whether plaque lipid content predicts future macrophage proliferation rates in untreated individuals.
What This Would Prove
Whether plaque lipid content predicts future macrophage proliferation rates in untreated individuals.
Ideal Study Design
A prospective cohort of 150 patients with subclinical atherosclerosis, undergoing baseline plaque lipid quantification via MRI-PDFF and Ki67+ macrophage assessment via biopsy, followed by repeat biopsy after 18 months without lipid-lowering therapy.
Limitation: Biopsy risk limits longitudinal sampling; selection bias in who consents to biopsy.
Controlled Animal StudyLevel 4Whether direct lipid loading of macrophages in plaques increases proliferation independently of systemic cholesterol.
Whether direct lipid loading of macrophages in plaques increases proliferation independently of systemic cholesterol.
What This Would Prove
Whether direct lipid loading of macrophages in plaques increases proliferation independently of systemic cholesterol.
Ideal Study Design
A study in APOE*3-Leiden.CETP mice with established plaques, injected with lipid-loaded nanoparticles directly into plaques vs. control nanoparticles, measuring local macrophage proliferation (BrdU/Ki67) and lipid content via mass spectrometry over 7 days.
Limitation: Nanoparticle delivery may trigger inflammation unrelated to lipid content.
Evidence from Studies
Supporting (0)
Contradicting (1)
Inhibition of macrophage proliferation dominates plaque regression in response to cholesterol lowering
When fat levels in artery plaques go down, the immune cells (macrophages) stop multiplying as much — so more fat doesn’t make them multiply more, it’s the opposite.